Bmf (C-Terminus) antibody

Bcl-2-modifying factor
Bcl2 modifying factor
Gene name: BMF
As low as $738.10
In stock
In healthy cells, Bmf associates with the dynein light chain 2 component of the myosin V motors and is sequestered by the cell’s actin cytoskeleton. Disruption of the actin cytoskeleton, either by depolymerization of actin filaments or by detachment of cells from the extracellular matrix, triggers release and activation of Bmf, initiating the downstream apoptotic program. Bmf is constitutively expressed in many tissues.
More Information
ID Covalab pab60049
Product type Primary antibodies
Clonality Polyclonal antibody
Raised in Rabbit
Immunogen Peptide corresponding to aa 171-184 (C-terminal part )of human Bmf (accession no. NP_277038).
Activity cross reaction Reacts with the C-terminus part of human Bmf.
Species Hu
Labelling None
Form Purified
Preservative NaN3 0.02%
Storage instructions Stable for at least one year at -20°C. Avoid multiple freeze-thaw cycles.
Target Bmf
Uniprot ID Q96LC9
Gene ID 90427
Applications IF, IHC, WB
Working dilutions Optimal dilution should be determined by the end user.
The following are guidelines only:
WB (2.5 - 5 µg/ml)
IF (10 µg/ml)
Write Your Own Review
Only registered users can write reviews. Please Sign in or create an account